The new rules will make it illegal to sell puppies younger than eight weeks and require anyone breeding and selling three or more litters of puppies a year to apply for a formal licence.
Those needing a licence, including online sellers, will also be required to display their permit in any advertising, and to give owners information about the five welfare needs that owners must meet under the Animal Welfare Act.
The penalty for breaking the new law will be an unlimited fine and/or up to six months in prison.
The plans also cover how pet shops, boarding houses and riding stables are licensed, introducing a single 'animal activities licence' to improve the process and make enforcement easier.
Environment Secretary Andrea Leadsom said: "Everyone who owns a pet or is looking to introduce one into their life will want to know that the animal has had the very best start to life. Yet for thousands of puppies born each year to irresponsible breeders, from smaller operations to larger puppy farms, their first weeks are spent in cramped and squalid conditions without the care and attention they need. That is why we are cracking down on the worst offenders by strengthening the dog breeding licence and giving councils the power they need to take action.
With more and more pet sales now taking place on the internet, it’s right that this market is subject to the same strict licensing criteria as other breeders and pet shops so that consumers are not misled. The plans announced today will help people choosing new family pets to be confident the animals have been properly bred and cared for from birth and are ready to move safely to their new homes.
Gudrun Ravetz, President of the British Veterinary Association, said: "This is a significant step in the right direction to improve the welfare of puppies and dogs in the UK, an issue our members are extremely concerned about as increasing numbers of poorly bred puppies are brought into veterinary practices.
"Poorly bred and badly socialised puppies cause terrible health and welfare problems for dogs so it is right that Defra has made irresponsible dog breeding a priority. We particularly welcome the move to make the sale of a puppy under eight weeks illegal, the reduction in the number of litters bred requiring a formal breeder’s licence, and the moves towards a single animal activities licence. In the future we would also like to see that anyone breeding from a dog should be required to register with their local authority.
"For these new measures to work in practice local authorities must have the necessary resources and support to fully enforce the legislation, supported by local veterinary expertise.
"We hope the new legislation will encourage owners to stop and think about where they’re getting their puppies from to tackle irresponsible breeding both at home and abroad. Prospective owners should do their homework and always use the puppy contract and information pack to make sure they ask breeders the right questions for a happy, healthy puppy."
The Kennel Club and Dogs Trust have welcomed the announcement.
Dogs Trust Veterinary Director, Paula Boyden said: "As the UK’s largest dog welfare charity, Dogs Trust welcomes the Government’s review of animal establishments licensing in England and the range of measures it sets out.
"We are particularly pleased that it will be illegal to sell a puppy below the age of 8 weeks and that there will be tighter licensing rules which will require sellers of pets to display their licence when advertising. We also applaud the move towards a risk based single licensing system which will incorporate those breeders that have gained UKAS approval rather than exempting them.
We believe that Local Authority Inspectors need support to enforce these tighter licensing rules. As such, moves to mandate the use of Model Conditions and for inspectors to be offered training and standards to be set is most welcome."
The new maternity policy will offer enhancement at 100% of full pay for 10 weeks, and 50% of full pay for a further 10 weeks, without any clawback provision should mothers decide not to return to CVS after their leave.
As part of the Time To Change Pledge, CVS will submit a plan for introducing evidence-based interventions and policy to help its employees work in ways that promote positive mental wellbeing.
CVS's plan includes the appointment of 250 Wellbeing Champions who will be trained in first aid for mental health. The company also plans to roll out further training on managing stress and mental health issues for line managers in 2020.
Richard, pictured right, said: "We are proud to be the first major veterinary employer to sign the Time to Change Pledge. The CVS wellbeing working party have made much progress in the last 12 months delivering our plan which has been formalised through participating in the Time to Change pledge.
"We recognise that the pressures in our industry are significant and unique, and that there’s more work to do. We remain committed as a company and wellbeing working party to changing the way we all think and act about mental health in the workplace for the better."
Virbac has launched of Bovigen Scour, an emulsion for injection into cattle which reduces the severity of diarrhoea caused by bovine rotavirus, bovine coronavirus and enteropathogenic E.coli F5 (K99).
Bovigen Scour works by actively immunising pregnant cows and heifers and providing passive immunity to their calves via colostrum. According to the company, the vaccine also helps to reduce the shedding of virus by calves infected with bovine rotavirus and coronavirus.
Virbac says a key benefit of Bovigen Scour is the vaccination protocol which offers a large window for injection, making it easier for vaccination planning. The primary course is administered in two shots, with first dose between 12 and 5 weeks before calving and the booster 3 weeks later. The annual booster is then due between 12 and 3 weeks before calving is expected. The vaccine is presented in two sizes: 15ml (5 doses) and 90ml (30 doses). The dosage per cow is 3 ml and the withdrawal time is nil in milk.
Virbac Large Animal Product Manager Brigitte Goasduf MRCVS said: "Bovigen Scour offers farmers flexibility and ease of use. The flexibility it gives in terms of scheduling the primary course and booster is particularly important and is highly relevant for beef cattle farmers as it can be difficult to know exactly when a cow is likely to calve and it is vital not to miss the vaccination window.
"Bovigen Scour is also convenient to give because of the small volume of emulsion and because the injection is given intramuscularly. Its launch extends our large animal vaccine range, which includes Gudair, for the active immunisation of sheep and goats against Mycobacterium avium subspecies paratuberculosis (Map)."
95% of the vets surveyed by the company reported success treating cats with Thyronorm Oral Solution for Cats, while 89% expected the liquid solution to improve compliance in the management of hyperthyroidism.
93% also said they found Thyronorm gave them an easier way to offer cats a low dose, or an 'in-between' dose, as it can be titrated 'to effect' – meaning the dose of treatment can be varied more easily to suit the individual animal.
Feline hyperthyroid specialist Dr Sarah Caney said she is unsurprised by the survey results: "Treatment is complex for cats needing a low dose, or an ‘in between’ dose, as standard anti-thyroid tablets are only available in a small number of dose sizes and are not designed to be split, halved or quartered. Also, if a cat is on alternating doses, it can be difficult for carers to remember which dose is due today."
Rachel Crowe, Norbrook’s Companion Animal Senior Product Manager, said: "We are delighted that overall 99% of the 200 veterinary surgeons surveyed would recommend Thyronorm in the management of hyperthyroidism, compared to other medical options."
Thyronorm contains 5mg/ml of thiamazole (methimazole). The initial starting dose is 5mg active ingredient per day, split into two doses.
Available in 30ml and 100ml bottles, with an in-use shelf life of six months, Thyronorm is available to order from all UK veterinary wholesalers.
Briar House Veterinary Surgery achieved 944 top rated reviews over the past 12 months, with pet-owners leaving comments such as 'Absolutely fantastic would recommend to everybody', 'Brilliant all round service' and 'You can tell that they love and care for the animals as much as the owners do'.
Briar House said: "We are absolutely delighted to win the Vet Help Direct Best UK Vet award, it means so much to the practice and team. We would like to say a big thank you to all of our wonderful clients and patients for taking the time to review your experience with us. We are very proud of our surgery, so it is a pleasure to receive such positive feedback from our clients."
Silver and Bronze Awards were achieved by Vets 1 Group and St Anne’s Veterinary Group, with 350 and 330 top reviews respectively. Other winners included Lamond Veterinary Clinic (Best Scottish Vet), Bridgnorth Veterinary Centre (Best Small Practice), Penmellyn Equine Vets (Best Equine Vet), Medivet The Vets Hendon (Best London Vet), The Mobile Vet (Best Mobile Vet), St James Veterinary Group (Best Welsh Vet) and Cedar Grove Veterinary Clinic (Best Northern Ireland Vet).
The full list of results, including those making the Top 25, can be viewed here.
Susie Samuel, Managing Director of VetHelpDirect said: "Reviews are a great way to find out what your clients really think, offering insight into where you are excelling or where there could be improvements. They are also excellent for building your online reputation, which will give you the competitive edge over other local practices, ultimately leading to new clients.
"More than ever, people are using review sites to seek 'real' opinions, in fact a recent survey in the US found that 97% of consumers read online reviews for local businesses, and 85% of consumers trust online reviews as much as personal recommendation.1 While these numbers may not truly reflect the situation in the UK veterinary industry, they are quite staggering, and signal that reviews and online reputation is going to become increasingly more important.
For more information about building your online reputation, contact Vet Help Direct on 0845 4961 204 or email: info@vethelpdirect.com.
Reference:
According to the study1, which looked at Chihuahuas treated in first opinion practice, ownership in the UK has increased over five-fold in the past decade from 1.0% of all puppies born in 2005 to 5.4% in 2016.
However, the study also found the breed was particularly susceptible to a number of health issues, including: dental disease (13.5%), obesity (5.9%) and retained baby teeth (5.7%).
Compared with other dogs, Chihuahuas were also more prone to aggression (4.2%), slipping kneecap (4.0%) and retained testicles (3.9%).
Other findings included:
Dan O’Neill, senior lecturer at the RVC and author of the paper, said: "Chihuahuas are an old breed but the recent craze for them can cause some real welfare issues for this tiny dog. There is increasing evidence that unscrupulous breeders and dealers both inside and outside the UK are cashing in on this trend by making a lot of money but with little regard for the welfare of these puppies and breeding bitches."
Camilla Pegram, VetCompass epidemiologist at the RVC and co-author of the paper said: "Dental disease and retained baby teeth should be recognised as important health concerns for Chihuahuas, with preventative care for dental disease a key topic for discussion between vets and owners. In addition, many of the common or predisposed disorders, such as dental disease, retained baby teeth, sliding kneecap and retained testicle(s), often require surgical intervention. The Chihuahua’s small size increases its anaesthetic risk. Obesity has many detrimental effects, including increased anaesthetic risk, and aggression makes them challenging patients and pets, therefore nutrition, lifestyle and behaviour are also key areas for veterinary-owner discussions."
The full paper is open access: https://doi.org/10.1186/s12917-020-2258-1.
Genitrix has launched Libromide, the first licensed formulation of potassium bromide for the treatment of canine epilepsy, following what the company believes to be the largest ever trial of dogs suffering from epilepsy.
Genitrix says the availability, for the first time, of a licensed formulation of potassium bromide should give veterinary surgeons and pet owners the reassurance that the rigorous authorisation process provides. It ensures, for instance, that the product has been developed especially for dogs and that it is manufactured in accordance with EU regulations. It also ensures that the product has been extensively and independently trialled, proven to be efficacious without adverse reactions, and that the necessary pharmacovigilance is in place to support it.
The company also says that the availability of a licensed product paves the way for more comprehensive information to be provided to veterinary surgeons on the use of potassium bromide in treating seizures. The Veterinary Medicines Directorate (VMD) imposes restrictions on educational materials supplied by manufacturers of unlicensed products, an approach which has created a 'knowledge gap' among many veterinary surgeons in general practice, according to some canine epilepsy experts.
Libromide tablets are intended for use in epileptic dogs which have already commenced therapy with Phenobarbital. Phenobarbital acts to increase the effects of the GABA inhibitory neurotransmitter in the central nervous system. Potassium bromide is synergistic with Phenobarbital and raises the seizure threshold level in epileptic dogs.
Libromide is classified as POM-V and will be available in 325 mg tablets in packs of 100 and 500 tablets.
Rodolfo Cappello DVM PhD DipECVN MRCVS, RCVS and European Specialist in Neurology and Neurosurgery, Head of Neurology Services at North Downs Specialist Referrals, Surrey, said: "I've been successfully using potassium bromide for the treatment of epilepsy in dogs for over 15 years. The main problem has been that it's not been licensed as a medicine. With the launch of Libromide, potassium bromide finally achieves the status of an approved pharmaceutical. We will now be able to monitor quality, efficacy and side effects which will enable us to offer a more professional approach to the treatment of seizures."
Howard Wilder, founder and managing director of Genitrix, added: "Canine epilepsy is an all too common disease with estimates suggesting it affects four in every hundred dogs in the UK. It's also an illness which is not well enough understood with the lack of up to date information available to veterinary surgeons being a contributing factor.
We felt there was an opportunity to bring a licensed product to market and have invested hundreds of thousands of pounds in the process of development and trialling Libromide. We're delighted to make it available to veterinary professionals and hope its launch will be the first step in improving treatment approaches for this distressing disease."
Vets Now has published a response to the RCVS DC ruling in which Munhuwepasi Chikosi, a locum working for the company, was struck off for delaying an emergency OOH home visit.
The response is available in full here: http://www.vets-now.com/news/?item=4191
Mr Shillabeer faced five charges which largely related to his alleged prescription of contra-indicated NSAIDs and corticosteroids.
He was also charged with prescribing frusemide to a pregnant dog when there was no evidence of a benefit of so doing.
He was also charged with performing inadequate spay surgery.
Mr Shillabeer did not admit to any of the charges, engaged with the College and responded to all requests for information, as well as being present in-person at the hearing.
He made an application to the Committee to dispose of the matter by way of adjournment, subject to the Committee accepting his written undertaking to remove his name from the Register and never to apply to be restored to the Register.
In support of his application, Mr Shillabeer’s legal counsel referred to his client’s witness statement, which set out that he had previously attempted to sell his practice but had been unsuccessful and that he had since closed it.
His legal counsel also asked the Committee to consider the fact that Mr Shillabeer is almost 85 years old and has had an unblemished 60-year career, has had no previous disciplinary findings against him, had put his practice up for sale and made efforts to guide his previous clients to ensure continuity of care elsewhere, and that he deeply regrets anything he has done, which has failed to protect the welfare of animals, or has caused concern or upset to his clients and fellow members of the profession.
Mr Shillabeer's counsel also asked the Committee to take into consideration that his undertakings would have the effect of protecting the welfare of animals and uphold the reputation of the profession as Mr Shillabeer is no longer in practice.
He stated it would be not proportionate, or in the public interest, for there to be a lengthy contested hearing resulting in substantial costs for both the RCVS and Mr Shillabeer.
The College’s legal representative stated that the RCVS did not oppose the application, and that it took a neutral stance.
She highlighted that Mr Shillabeer’s removal from the Register, together with his undertaking never to apply for restoration, would go far beyond anything the Committee could direct by way of sanction after a full enquiry, that Mr Shillabeer retired from practice on 23 July 2024 and does not intend to return, that a full enquiry would take a significant amount of time and expense, that the complainant supports the case being dealt with in the manner proposed by Mr Shillabeer, and that there are no previous findings against Mr Shillabeer.
Paul Morris, chairing the Committee and speaking on its behalf, said: “Taking into account the undertaking never to practice again, in conjunction with all of the circumstances and context set out, the Committee considered that by allowing the application, such an outcome would be sufficient to uphold the public interest, confidence in the profession and the RCVS as regulator, and protect the welfare of animals.
“As a result of all the factors set out, the Committee decided that this is not a case in which the public interest or the welfare of animals demands that there be a full hearing.
“Taking into account proportionality and weighing in the balance all the circumstances of the case, the interests of justice, the public interest, the need to uphold proper standards of conduct and performance, and the need to protect the welfare of animals, the Committee decided to grant the respondent’s application.”
Mr Shillabeer was removed from the Register with immediate effect.
https://www.rcvs.org.uk/concerns/disciplinary-hearings/
The Mayor of Loughton, Councillor Philip Abraham, officially opened the Vets4Pets Loughton veterinary surgery inside Pets at Home at the Epping Forest Shopping Park, before enjoying a guided tour of the bright and modern facility.
Cheryl, who stars in the BBC’s children’s TV show The Pet Factor, said: "It’s fantastic to be able to open the doors to Vets4Pets Loughton and reach a landmark number of practices for the group.
"The opening event gave us chance to meet new clients, and welcome them to the practice."
Cheryl qualified in 2009 and is also a joint venture partner at Vets4Pets Chadwell and Newbury Park in Ilford.
Nick, who qualified in 2008, is also joint venture partner at Newbury Park, Romford, Beckton and Dagenham.
Nick said: "I have always been interested in caring for pets and have several dogs and cats at home.
"I love being a veterinary nurse and I’m delighted to have another opportunity from Vets4Pets to open my fifth practice.
"Once again the process to open a practice has been easy and we’ve had brilliant support on all aspects from Vets4Pets.
"I’m now looking forward to welcoming pets and their owners to Vets4Pets Loughton and providing the highest standard of veterinary care to the area’s pets."
The new practice will create five new jobs, with two vets, veterinary nurse, two pet care assistants and a receptionist.
Chief executive of the Pets at Home Vet Group, Andrei Balta, said: "Cheryl and Nick are two great advocates for the veterinary profession and we’re delighted they are part of the group.
"Wherever we have opened, pet owners have responded enthusiastically to our state-of-the-art practices and convenient opening hours.
"The joint venture model we operate across our practices provides the support vets and vet nurses need to run their businesses.
"It allows them to focus on what they really love, looking after the health of animals, while the support team helps with other areas including marketing, HR and business strategy."
The referral centre recently extended its floor space at its base in Cheshire to support a major expansion of the services being offered, which include orthopaedic, soft tissue and spinal surgery and internal medicine; with specialist support in anaesthesia and pain management, a diabetes clinic, intensive care, cardiology, diagnostic imaging, neurology (medical and surgical) and oncology.
Liz Cousins, hospital manager at Northwest Veterinary Specialists, said: "The success of NWVS is down to the dedication of our highly skilled clinical, nursing and support teams.
"Our clinicians are well respected specialists in their chosen disciplines and it’s fantastic to be able to offer new services to pets and first opinion vets.
"The hospital is home to 88 colleagues and the change of name now reflects the growth and dedication by everyone here at Northwest Veterinary Specialists since opening in 2002."
Northwest Veterinary Specialists provides specialist veterinary services to veterinary practices in north west England and north and mid Wales.
Liz added: "At Northwest Veterinary Specialists we treat pets from as far apart as Carlisle, North Yorkshire and Staffordshire.
"The facilities are state-of-the-art, demonstrating a quality of service both for our clinicians and our clients, but most importantly the pets that we treat."
Surrey vet Matthew Morgan has been struck off by the RCVS Disciplinary Committee after being convicted and imprisoned for four counts of pet insurance fraud.
Mr Morgan was convicted, upon his own confession, of dishonestly making false representations to make gain for himself/another or to cause loss to other/ expose other to risk on 22 July 2013 at the Central Criminal Court and, on 23 August 2013, was sentenced to two years' imprisonment.
The Disciplinary Committee heard that Mr Morgan, who was not present at the hearing but represented by Mr Laurence Imrie, Solicitor Advocate, had, between 13 November 2009 and 21 December 2012, taken out 18 insurance policies for veterinary cover with four separate insurance providers - Direct Line, Pet Plan, Pet Protect and Sainsbury's - in relation to a number of pets. Of these pets, only one, namely his pet cat, actually existed - the rest were fictitious.
During this period, the respondent made 50 claims on the insurance policies, seeking payment to reimburse him for the cost of veterinary treatment for the fictitious animals and also making false claims for treatment for his own pet cat, including for invented injuries 'sustained' during a non-existent car accident. As a result of the claims, the insurance companies made 54 payments to Mr Morgan to which he was not entitled, totalling £198,295.
At the time he began committing the offences Mr Morgan was working as a veterinary surgeon at a practice in Kent and, in order to support his fraudulent claims, used the practice's official stationery and stamps to fabricate invoices, clinical records and insurance claims. He continued to make fraudulent claims after leaving the practice, having taken the practice's headed paper and stamp with him.
Mr Morgan's actions came to light in December 2012 after submitting a claim to Direct Line for an operation on the spine of his own cat. The insurance company became suspicious and contacted the Kent practice which confirmed he had not treated the cat. An investigation by the insurers and, subsequently, the police began.
On 31 December 2012 Mr Morgan voluntarily attended a police station where he admitted fraudulently claiming £5,534.52 from Pet Plan and £7,610.03 from Direct Line, citing financial pressure caused by divorce, but failed to admit to the rest of his fraudulent activities. He was arrested on 25 January 2013 and, upon searching his home, police found the stamp and headed paper along with documents relating to the insurance claims.
The Disciplinary Committee, in considering the conduct of Mr Morgan, took into account a number of serious aggravating factors. This included the very high degree of financial gain from the fraudulent activities, the fact that there were 50 separate premeditated acts of dishonesty over a three-year period, the betrayal of trust of his former employer and the insurance companies, the potential reputational risk for his former employer, the abuse of his position as a veterinary surgeon and the fact that completion of insurance claims is an act of veterinary certification.
The Committee also considered, in mitigation, a letter from Mr Morgan to the Committee, three testimonials and representation from his legal representative. These cited the fact that Mr Morgan, when he committed the fraudulent activities, was heavily in debt, had serious domestic difficulties and was suffering from depression, although no medical evidence was submitted to the Committee.
However, it was the Committee's decision that the sanction of removing Mr Morgan from the Register had to be taken, in order to protect animal welfare and maintain public confidence in the profession.
Chairing and speaking on behalf of the Disciplinary Committee its Vice-Chairman, Ms Judith Webb, said: "The Committee is of the view that the Respondent's conduct in this case was deplorable ... Such conduct can only undermine public confidence in the profession. The Respondent abused his position as a veterinary surgeon to perpetrate a deliberate long-term fraud on insurers for personal gain.
"The Committee is conscious that its role is not to punish but to protect animal welfare and maintain public confidence in the profession. Due to the serious nature of the matters before it...the Committee has no doubt that the only suitable sanction is to direct the Registrar to remove the Respondent's name from the Register."
The Committee's full findings and decision are available on the RCVS website (www.rcvs.org.uk/disciplinary).
The practice has also strengthened its surgery services with the appointment of Dr Delphine Holopherne-Doran, European Specialist in Veterinary Anaesthesia and Analgesia.
Ivan graduated from Bristol University in 1997. He worked in Hertfordshire before completing a surgical residency under the tutelage of Professor Peter Holt at Bristol University. Ivan has worked in referral centres in the UK and France. He is an RCVS Diplomate in Small Animal Soft Tissue Surgery and a Recognised Specialist in Small Animal Soft Tissue Surgery. Before joining Highcroft, he spent six years working as a senior staff surgeon at Bristol University.
Ed graduated from the Royal Veterinary College (RVC) in 1996. He worked in a mixed practice in Buckinghamshire before undertaking training positions at the RVC, University of Liverpool and the University of Cambridge. He passed the specialist Diploma examinations of the European College of Veterinary Surgeons in 2003. He has previously been a senior surgeon and member of academic staff at the University of Bristol and has worked in private referral practice.
Delphine graduated from Maisons-Alfort (Paris) Vet School in 1998. After working as an equine vet, where she developed an interest in veterinary anaesthesia and analgesia, she returned to vet school in Nantes where she ran the Anaesthesia department for 11 years. During this time, she gained a Master’s degree and a PhD in cardiovascular pharmacology and completed a residency, gaining European board certification in anaesthesia and analgesia, which led her to visit and train in universities around the world.
Highcroft Hospital Director Mr Chris Mayers said: “Ivan and Ed bring a wealth of experience in urinary tract surgery and, in particular, in urinary incontinence to Highcroft. The most common presentations are juvenile animals with ectopic ureters or urethral sphincter mechanism incompetence (post-spay incontinence). Ivan and Ed offer an innovative, minimally-invasive procedure using cystoscopically-guided laser ablation for patients with intramural ectopic ureters. Interventional radiology techniques are also a major interest for the team providing new, minimally-invasive solutions for intrahepatic shunts. The two surgeons have firmly adopted Subcutaneous Ureteral Bypass Systems (SUBS) in treating cats with ureteral obstruction, typically caused by calculi.
"Delphine adds world-class expertise in anaesthesia and analgesia and is already making a huge contribution to our hospital. With a high degree of skill in managing cardiovascular physiology and pharmacology cases, Delphine boosts our ability to support highly challenging and complex patients. Her knowledge of the use of local and region blocks for treating highly challenging pain cases and the anaesthesia of complex cardiovascular patients provides outstanding care for patients and promotes the highest standard in analgesia."
Highcroft Veterinary Group is based at 615 Wells Road, Whitchurch, Bristol and can be contacted on 01275 832410.
Neuro orthopaedic veterinary surgeon Noel Fitzpatrick has been having a busy old time: hot on the heels of his world-first procedure to implant a prosthetic hip and femur in an American Bulldog comes the news that he has now fitted a cat with titanium prosthetic paws in another world-first.
Oscar the cat was minding his own business, basking in the late summer sun, when a passing combine harvester chopped off his hind paws.
Unlucky.
However, Oscar's luck turned when his veterinary surgeon, Peter Howarth from St Saviour in Jersey, referred owners Kate and Mike Nolan to Fitzpatrick Referrals to investigate the possibility of giving Oscar a pair of prosthetic paws.
Kate said: "We had to do a lot of soul-searching and our main concern has always been whether this operation would be in Oscar's best interests and would give him a better quality of life". Having decided it would, the Nolans asked Noel to go ahead. And so he came to give the two-year-old cat a pair of new artificial feet in a single, three-hour surgical procedure - something he says has never been done before by any team anywhere in the world.
The revolutionary design of the feet uses custom-made implants to 'peg' the ankle to the foot and mimics the way in which deer antler bone grows through skin. These pegs, or ITAPs (intraosseous transcutaneous amputation prosthetics), were first developed by a team from University College London led by Professor Gordon Blunn, Head of the Centre for Bio-Medical Engineering at UCL's Institute of Orthopaedics and Musculoskeletal Science. Working in partnership with UCL, Fitzpatrick has pioneered the use of these weight-bearing prosthetic implants.
During the operation, the veterinary surgical team had to insert the ITAPs by drilling into one of the ankle bones in each of the back legs - an extremely delicate feat, which could have fractured the ankle joint before the procedure had even begun, and even more challenging because it had to be performed twice. These artificial implants which are attached to the bone at an amputation site are coated with hydroxyapatite, which encourages bone cells to grow onto the metal. The skin then grows over the special umbrella at the end of the ITAP to form a resilient seal against bacteria and potentially fatal infections. The ITAP itself protrudes through the bone and skin, allowing the custom-built artifical paws to be attached securely. Click here to see x-rays and other case photos in the VetSurgeon media gallery.
Following successful surgery in November last year, the focus of the veterinary team has turned to the slow process of rehabilitation and helping Oscar to learn to walk again - firstly using external scaffolding anchored to the tibia to protect the new implants until the ITAPs integrated into the bone and the skin grew onto the ITAP. Remarkably Oscar was trying to stand within a day of the operation and despite some problems with infection that had to be overcome, in less than four months Oscar could stand and bear weight equally on all four limbs. He has since been fitted with a series of prototype new paws to ensure the best possible long term fit.
What makes this procedure so complicated is that Oscar's feet were severed at the junction of the tarsus and metatarsus. Noel said: "The real revolution with Oscar is because we have put a piece of metal and a flange into which skin grows into an extremely tight bone, with very narrow tolerances in the region of nanometres, rather than millimetres. We have then successfully managed to get the bone and skin to grow into the implant and we have developed an exoprosthesis that allows this implant to work as a see-saw on the bottom of an animal's limbs to give him effectively normal gait. Oscar can now run and jump about as cats should do.
Noel Fitzpatrick and the team at Fitzpatrick Referrals are the focus of a new six part documentary series: The Bionic Vet to be broadcast on BBC 1 at 10.45 pm every Wednesday starting on 30 June 2010. The programmes will focus on the multi million pound state-of-the-art vet practice in Surrey as well as the ways in which Noel is pioneering revolutionary new surgical techniques.
Effipro Duo contains fipronil to kill adult fleas and ticks, and pyriproxyfen, an insect growth regulator, to sterilise adult fleas and inhibit the immature life stages. It provides three months protection against flea life cycle completion.
The product is presented in Effipro’s patented ‘drop-lock’ pipette, designed to ensure that the solution is released only when the owner is ready.
Effipro Duo is offered in packs of 4 pipettes and in a 24-pipette dispensing pack to suit practices offering health plans.
Product Manager Kate Woolley MRCVS said: "Because Effipro Duo targets not just the adult fleas on the pet but also the key developmental stages in the flea life cycle often found in the home, it represents an integrated and easy-to-use solution, both for on-animal flea and tick control and for long-lasting protection of the home environment.
"Household flea infestations are common all year round and experts agree that the combination of an adulticide and an insect growth regulator is the most effective way for owners to protect their homes from this unpleasant problem¹. For complete flea control in the home, we recommend that it is used in conjunction with Indorex®, the UK’s no. 1 household flea spray².
"Virbac offers one of the most extensive parasiticide ranges on the market and we believe Effipro Duo will provide a popular addition, offering owners long-lasting protection from fleas and ticks for their cats and dogs, while helping practices to retain vital parasite control sales in-house."
References
Mr Roger faced three charges: that he had failed to provide adequate care, failed to communicate with the owner adequately and failed to keep adequate clinical records for Honey, a Shiih Tzu dog who, it transpired, had hypergycaemia.
At the initial consultation, Mr Roger took a blood sample which showed that there was an elevated blood glucose, an elevated white blood cell count, an elevated ALT and an elevated ALP (which Mr Roger took to be indicative of liver damage secondary to infection).
Mr Roger prescribed a cholagogue (ursodeoxycholic acid), an antibiotic (Synulox) and a diuretic (Frusemide).
In its findings of fact, the Committee found it likely that Mr Roger would have realised that Honey had a potential diabetes mellitus diagnosis with an elevated blood glucose of 28.
However, Mr Roger explained that he had believed the elevated blood glucose was due to the stress Honey had undergone in taking the blood samples.
The Committee therefore accepted that Mr Roger’s actions did not indicate a complete failure by him to notice the elevated blood glucose because he had explained he believed at the time it was due to stress.
Honey’s owner took her back to the veterinary practice that Mr Roger worked at three days later.
A different veterinary surgeon examined Honey and flagged that her blood sugar was high and that her liver was damaged.
She was taken to an alternative veterinary practice for follow-up but died later that day.
Mr Roger admitted failing to ask Honey’s owner if there was a history of diabetes mellitus, failing to take repeat blood glucose tests or carry out urine analysis or carry out additional blood tests, failing to communicate adequately with Honey’s owner about the significance of the hyperglycaemia and the options for investigation/management and failing to keep adequate clinical records in regard to Honey’s blood glucose levels.
The Committee found the admitted facts proved.
The evidence presented to the Committee included the clinical notes taken during Honey’s consultations, emails sent from Honey’s owner to the RCVS outlining the complaint, and evidence from experts in small animal veterinary practice.
Although the Committee found some matters not proved, it did find proved that Mr Roger had failed to recognise and/or pay adequate regard to Honey’s elevated blood glucose levels, had failed to manage Honey’s hyperglycaemia either by treating it or by documenting an appropriate plan to do so and had failed to communicate adequately with Honey’s owner about the significance of her elevated glucose and the reason for it.
Having reached its decision in relation to the facts, the Committee went on to consider whether the facts it had found proved either individually or cumulatively amounted to serious professional misconduct.
Judith Way, Chairing the Committee and speaking on its behalf said: “The Committee found that the charges and particulars it had found proved did not amount to disgraceful conduct in a professional respect either individually or cumulatively.
"In its judgment, the conduct found proved fell short of the standard to be expected of a reasonably competent veterinary surgeon but not far short of the standard which is expected of the reasonably competent veterinary surgeon.”
As a result of the Committee finding that Mr Roger was not guilty of serious professional misconduct on any of the proven charges, either individually or in any combination, the hearing did not proceed further.
Zoetis has announced the launch of Ketavet.
The intravenous anaesthetic solution containing ketamine is available in 10ml and 50ml presentations. The new product coincides with the re-classification of ketamine as a schedule 2 drug.
Ketavet is a clear, colourless solution for injection containing ketamine 100 mg/ml (equivalent to 115.36 mg/ml ketamine hydrochloride) with benzethonium chloride 0.1 mg/ml as a preservative. It can be used to induce anaesthesia in horses in conjunction with xylazine, detomidine or romifidine.
Ketavet, along with other ketamine containing products, has been moved to Schedule 2 of the Misuse of Drugs Regulations, which took effect from 30 November 2015. This enables tighter controls on the record keeping, prescribing and safe custody of products containing this active. More information on the specific requirements which will need to be met following the schedule change can be found on the VMD website https://www.gov.uk/government/news/amendments-to-the-misuse-of-drugs-regulations-2001
Penny McCann, Equine Product Manager at Zoetis said: "Ketavet is an important product in our anaesthesia portfolio. We are keen to help veterinary surgeons keep up-to-date with the reclassification of ketamine and with this in mind our new product packaging clearly reflects ketamine’s revised status as a schedule 2 drug."
For more information, contact your Zoetis Account Manager.
A graduate of University College Dublin, Richard started out in first opinion practice after completing an internship at the University of Glasgow.
While studying medicine, Richard researched mast cell tumours in dogs, which led to an MSc in clinical Oncology. He went on to complete a PhD on mast cell tumours at the Royal Veterinary College in 2008.
Richard works with referral oncology patients and clients two days a week at LVS and currently spends the rest of his working week as an oncology consultant for IDEXX Laboratories.
From February, Richard will also be working at Southfield Veterinary Specialists in Laindon, Essex, thereby allowing him to refer oncology patients for radiation therapy at Southfields when necessary.
Richard said: "Having never been comfortable with operating myself, working with a team of this calibre and experience in a welcoming environment within central London was very attractive. It has been a very fulfilling role for me, especially as both our team and the scope of the services we can offer continue to expand.
"Given the high standard of care offered by local vets in the area, the patients referred to LVS are often very challenging. Together with our clients’ high expectations, the service is definitely not run-of-the-mill but all the more rewarding because of that.
"I’m looking forward to bringing my experience in both research and clinical spheres to LVS."
Richard’s main professional interests are mast cell tumours, novel diagnostics and immunotherapeutics, but he is experienced in all aspects of veterinary oncology and can also offer advice about internal medicine cases.
This latest incarnation of the FECPAKG2 is now a battery-powered and wi-fi enabled. This means it can pair with smartphones, tablets and laptops, allowing samples to be uploaded, analysed and results received, virtually anywhere.
Tabitha Allen from Techion said: "The technology allows internet connected and image-based FEC testing to be carried out literally on the job.
"While the current system is able to return results rapidly, samples need to be uploaded via a computer. The upgrade will therefore give users more flexibility, allowing samples to be processed away from the office."
"Samples are then analysed by trained online technicians so we can confidently provide accurate results, which can then help farmers make informed decisions when it comes to worming.
"The new upgrade now includes a digital microscope that enhances image quality further, making it quicker and easier than ever before to provide these accurate results.
For more information, visit: www.techiongroup.com or ring: 01970 821 918
Based at UCLan’s Preston Campus, the new school will deliver foundation, undergraduate and postgraduate courses in areas such as veterinary medicine, bioveterinary science, veterinary clinical practice, veterinary physiotherapy and rehabilitation, and clinical animal behaviour and training.
Professor Graham Baldwin, UCLan Vice-Chancellor, said: “We’re absolutely delighted to be creating an innovative and dynamic veterinary school. UK veterinary schools are highly prestigious, so we are thrilled to be launching only the second school in the north of England and one of only 11 in the UK.
“We have taken massive strides in developing all areas of human health provision in recent years, and animal health will now join our ever-expanding portfolio of medicine, dentistry, pharmacy, biomedical sciences and optometry.”
Professor Cathy Jackson, Executive Dean of the Faculty of Clinical and Biomedical Sciences, said: “Our new veterinary school will be focussed on producing much needed industry ready graduates for our region, particularly as recent figures have highlighted a national shortage of vets and a sector heavily reliant on vets educated in the European Union.
"As with our medical and dental schools, we have demonstrated we want to break down barriers and make education accessible to all. It’s no different with our veterinary school and we want to open the doors and offer a pathway for any student, no matter of their background, into this rewarding profession, while maintaining the very highest of education and professional standards.”
The Batchelor of Veterinary Medicine and Surgery (BVMS) course at UCLan is a five-year programme with ‘hands-on’ modules from Year 1, rather than in the later years as delivered in more traditional programmes.
UCLan says it is collaborating with Myerscough College for some of its programmes to give students access to state-of-the-art, sector-leading facilities, which have recently benefited from a £35m investment.
In addition, UCLan will become one of the first universities in the world to make use of a digital, virtual dissection platform for teaching animal anatomy using veterinary Anatomage technology.
UCLan is planning to welcome the first intake of UK and international students to veterinary sciences BSc and foundation courses in September 2022 while BVMS students will be welcomed from 2023.
For more information, visit www.uclan.ac.uk/schools/veterinary-medicine.
Merial has announced the launch of Oncept IL-2, the first veterinary immunotherapeutic product in Europe for the management of cancer in pets.
Described by the company as a true breakthrough in the field of veterinary oncology, Oncept IL-2 is an adjunct immunotherapy for feline fibrosarcoma.
Merial says the product is based on recombinant canarypox vector technology it developed collaboratively with veterinary oncologists, and which is used in several of its vaccines, including PUREVAX FeLV and PUREVAX Rabies.
Oncept IL-2 is indicated for cats with fibrosarcoma (2-5 cm diameter) without metastasis or lymph node involvement, in order to reduce the risk of relapse and to increase the relapse-free interval. It should be used in addition to surgery and radiotherapy.
Kevin Whelan, Merial's Technical Manager said: "Following injection around the tumour surgery site, the recombinant canarypox vector virus enters the cat's cells, which then produce interleukin-2. The presence of this cytokine stimulates an anti-tumour immune response by a variety of mechanisms, including the induction of T-lymphocytes and natural killer cells."
In a field efficacy trial, a treatment course with Oncept IL-2 (consisting of 6 subcutaneous administrations in the tumour bed over a 7-week period), as an adjunct to surgery and radiotherapy, was shown to significantly reduce the risk of relapse and to increase the time to relapse.
The product is available in packs of 6 doses, which is sufficient for a treatment course. Please contact your local Merial Territory Manager for further information or email oncept@merial.com
VETNAPP offers a replacement to paper records and allows entry of drugs administered, physiological parameters (for example heart rate, respiratory rate and blood pressure) and complications occurring during an anaesthetic. The final anaesthetic chart can be converted to a PDF and attached to patient records.
Alastair said: "My motivation for creating the app was born of my frustration while working in Australia about how many handwritten anaesthetic records were incomplete and poorly filled in.
"I developed the app in partnership with an IT graduate at the University of Sydney. It is a replacement for paper records, with features such as you cannot move on to the next page until all data fields are complete. It also allows storage of thousands of records, therefore, allows easy retrieval of records, and prevents lost records which is common with paper records.
"I also would like to eventually have a cloud-based storage of data to allow anaesthesia studies such as drugs used, morbidity/mortality studies, to be carried out on a large scale basis, rather than single centre studies."
VETNAPP has been designed to meet the needs of both general practitioner veterinary surgeons and veterinary specialists in anaesthesia and analgesia.
At present, VETNAPP is only available for the iPad, priced at £59.99.
To download VETNAPP, go to: https://itunes.apple.com/gb/app/vetnapp/id980918731?mt=8.
For its research, the company surveyed 700 veterinary veterinary professionals.
The subsequent report, "Digital Adoption in Veterinary Medicine", provides up-to-date data on the levels of digital adoption by vets in the UK.
It also explores their attitudes to technology and digital communications tools, and the barriers to adoption. At the Zoom meeting, Scott Goodsir-Smyth, Provet Cloud’s VP of Growth for the UK & US will share and discuss some of the main findings of the report. He will also be answering questions about how practices can go digital, what the pitfalls are, how you can get the most value out of practice management software, and whether you should switch to the cloud. With the RCVS currently in the process of changing the rules regarding telemedicine, and only 23% of veterinary practices currently using telemedicine, this meeting could not be more timely. VetSurgeon.org and Provet are now inviting questions from vets about adopting digital technology, including online booking, integrated payments, pet owner apps, telemedicine, referral portals and digital whiteboards. The people who submit the best ten questions will be able to ask them before anyone else on the night and the best of the lot will get a bottle of champagne in time for Christmas.
To download the report, visit: https://www.provet.cloud/provet-cloud-digital-adoption-report To submit your question, email it to editor@vetsurgeon.org by Wednesday 9th November at 11:00am.
To register to join the Zoom meeting, visit: https://us06web.zoom.us/meeting/register/tZIsdOugpzMoGd0mrFcC_cyz1kNrGcwpMULV
ECM, a French manufacturer of ultrasound devices, has launched Exago, a new mobile veterinary ultrasound device which the company says is particularly suited for use with horses and pets.
ECM says the main features of the new device are:
For more information, visit: http://www.agroscan.com/
On 23rd March, the Government demanded that the majority of public-facing businesses close their doors. Veterinary surgeries, however, have been exempted and are allowed to remain open.
However, the number of clients seen face-to-face should be kept to an absolute minimum and veterinary teams must insist on strict social distancing measures at all times.
In addition, the RCVS/BVA say that:
The College has updated its FAQs for veterinary professionals, which can be found here: https://www.rcvs.org.uk/setting-standards/advice-and-guidance/coronavirus-covid-19/
The BVA is now developing some further guidance to provide examples of what constitutes routine, urgent and emergency care.